Cargando…
Neuroprotection in glaucoma
Neuroprotective therapies in glaucoma may play a role in preventing ischemia and oxidative damage that results in apoptosis of retinal ganglion cells and optic nerve damage. Although intraocular pressure (IOP) is the only known modifiable risk factor for glaucoma, disease progression commonly occurs...
Autores principales: | Vishwaraj, C R, Kavitha, Srinivasan, Venkatesh, Rengaraj, Shukla, Aakriti Garg, Chandran, Premanand, Tripathi, Shweta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023948/ https://www.ncbi.nlm.nih.gov/pubmed/35086201 http://dx.doi.org/10.4103/ijo.IJO_1158_21 |
Ejemplares similares
-
Changes in emergency glaucoma care during the COVID-19 pandemic in South India
por: Krishna, Umesh, et al.
Publicado: (2023) -
Access to eye care during the COVID-19 pandemic, India
por: Muralikrishnan, Janani, et al.
Publicado: (2022) -
Do motivational cards really benefit sibling screening of primary open-angle glaucoma probands?
por: Gurnani, Bharat, et al.
Publicado: (2022) -
The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment
por: Shalaby, Wesam S., et al.
Publicado: (2021) -
Reply to Comment on: The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment
por: Shukla, Aakriti Garg, et al.
Publicado: (2021)